April 14 (Reuters) - Neonc Technologies Holdings Inc NTHI.O:
NEONC TECHNOLOGIES HOLDINGS, INC. EXPECTS FULL ENROLLMENT IN PROMISING PHASE 2A TRIAL OF NEO100-01 FOR MALIGNANT GLIOMAS IN SEPTEMBER
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.